Streetbeat News

Regulatory

PLSE

Pulse Biosciences, Inc. has announced receiving all necessary regulatory approvals and completing required activities to begin its catheter ablation feasibility study. Additionally, Executive Chairman Robert W. Duggan is considering purchasing more shares of the company's common stock.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 7:55 pm

SEEL

The Department of Defense is funding a Phase 2 study to test Seelos Therapeutics' SLS-002, an intranasal racemic ketamine, on 600 service members and veterans for PTSD treatment. The study will assess safety, tolerability, and efficacy over a 12-week treatment period with a 30-day screening and four-week follow-up. Seelos has two IND applications with the FDA for SLS-002 for acute suicidal ideation and behavior in MDD and PTSD. The study, expected to start soon in Georgia, will be completed by 2026. PTSD incidence has risen among veterans, and ketamine shows promise as a rapid and effective treatment for depression, suicidality, and PTSD.

Portfolio Pulse from Lara Goldstein

November 27, 2023 | 7:48 pm

EIS

SPY

President Biden has stated that the current pause in fighting is being used to maximize the delivery of humanitarian aid to Gaza, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 7:20 pm

AMD

INTC

NVDA

TSM

Nvidia Corporation (NVDA) reported strong Q3 results with significant revenue and profit growth, driven by its Data Center division. Despite this, NVDA shares dropped due to the delay of its new AI chip launch in China to Q1 2024, complying with U.S. export curbs. Competitors TSMC (TSM) and Intel (INTC) also reported their Q3 results, with TSMC seeing a revenue drop but a QoQ increase, and Intel showing signs of recovery despite a minor loss. Advanced Micro Devices, Inc. (AMD) was mentioned as a competitor but did not have detailed financial results in the article.

Portfolio Pulse from Upwallstreet

November 27, 2023 | 6:45 pm

JNJ

Janssen, part of Johnson & Johnson, has submitted an application to the EMA for approval of RYBREVANT (amivantamab) in combination with chemotherapy for treating advanced EGFR-mutated NSCLC after prior therapy failure. The submission is based on Phase 3 MARIPOSA-2 study results, which showed significant improvements in progression-free survival compared to chemotherapy alone. Amivantamab was previously granted conditional marketing authorization by the European Commission in December 2021 for monotherapy treatment of NSCLC with EGFR exon 20 insertion mutations after platinum-based chemotherapy failure.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 6:36 pm

AMZN

GOOGL

MSFT

The U.S. and U.K., along with 16 other countries, signed an agreement on AI safety, emphasizing 'secure by design' principles. The agreement, influenced by CISA, NCSC, and major AI developers like Amazon, Alphabet, and Microsoft, aims to protect AI from misuse and enhance cybersecurity. The guidelines encourage AI developers to be aware of threats and incorporate best practices in cybersecurity and risk management. While only guidelines, some countries are considering regulation, and President Biden has ordered safety assessments for the AI industry.

Portfolio Pulse from Neil Dennis

November 27, 2023 | 6:23 pm

IRBT

iRobot shares are trading lower following concerns from the European Commission that Amazon's planned acquisition of the company may restrict competition.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 6:08 pm

AMZN

IRBT

VGK

The European Commission has expressed concerns that Amazon's acquisition of iRobot could restrict competition in the market for robot vacuum cleaners, particularly in the European Economic Area and/or national markets.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 6:03 pm

ETHUSD

On Sunday, 5,198.18 Ether (ETH) valued at approximately $10.46 million was burned, permanently removing it from circulation. This event is significant due to the Ethereum network's EIP-1159 upgrade, which introduced a variable base fee for transactions that is burned. The Ethereum 2.0 upgrade is expected to further reduce the annual issuance rate of Ether, potentially making ETH a deflationary currency. The net annualized issuance rate for Ether was -4.59% yesterday, according to Glassnode.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 6:00 pm

COIN

Coinbase Global, Inc. (NASDAQ:COIN) stock reached a new 52-week high of $120.34, driven by positive developments in the cryptocurrency sector. Bitcoin's new high, a settlement with Binance, the election of a pro-cryptocurrency president in Argentina, and anticipation of BlackRock's Bitcoin ETF have contributed to Coinbase's over 70% gain in the past month. Trading volume for COIN has exceeded its 100-day average.

Portfolio Pulse from Erica Kollmann

November 27, 2023 | 5:37 pm